Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 40-46

  McKimm Breschkin, Jennifer L ^a   Blick, Tony J ^a   Sahasrabudhe, Anjali ^a   Tiong, Tak ^a   Marshall, Deidre ^a   Hart, Graham J ^b   Bethell, Richard C ^b   Penn, Charles R ^b  

^a CSIRO   (Australia)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDO 2,6 ANHYDRO 3,4,5 TRIDEOXY 4 GUANIDINOGLYCERYLGALACTONON 2 ENOIC ACID; 5 ACETAMIDO 4 AMINO 2,6 ANHYDRO 3,4,5 TRIDEOXYGLYCERYLGALACTONON 2 ENOIC ACID; ANTIVIRUS AGENT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG RESISTANCE; ENZYME INHIBITION; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; STRAIN DIFFERENCE; VIRUS INHIBITION; VIRUS MUTATION;

EID: 0030053758     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.40     Document Type: Article

References (25)

1. Anders, E. M., A. A. Scalzo, G. N. Rogers, and D. O. White. 1986. Relationship between mitogenic activity of influenza viruses and the receptor-binding specificity of their hemagglutinin molecules. J. Virol. 60:476-182.
2. Baker, A. T., J. N. Varghese, W. G. Laver, G. M. Air, and P. M. Colman. 1987. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins 2:111-117.
3. Bean, W. J., S. C. Threlkeld, and R. G. Webster. 1989. Biologic potential of amantadine-resistant influenza A virus in an avian model. J. Infect. Dis. 159:1050-1056.
4. Burmeister, W. P., R. W. H. Ruigrok, and S. Cusack. 1992. The 2.2Å resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J. 11:49-56.
5. Daniels, R. S., S. Jeffries, P. Yates, G. C. Schild, G. N. Rogers, J. C. Paulson, S. A. Wharton, A. R. Douglas, J. J. Skehel, and D. C. Wiley. 1987. The receptor binding and membrane fusion properties of influenza virus variants selected using antihemagglutinin monoclonal antibodies. EMBO J. 6:1459-1465.
6. Dixon, M. 1953. The determination of enzyme inhibitor constants. Biochem. J. 55:170-171.
7. Grambas, S., M. S. Bennett, and A. J. Hay. 1992 Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses Virology 191:541-549.
8. Hart, G. J., and R. C. Bethell. 1995. 2,3-Didehydro-2,4-dideoxy-4-guanidinoN-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow binding inhibitor of sialidase from both influenza A virus and influenza B virus. Biochem. Mol. Biol Int. 36:695-703.
9. Hay, A. J., A. J. Wostenholme, J. J. Skehel, and M. H. Smith. 1985 The molecular basis of the specific anti-influenza action of amantadine EMBO J. 4:3021-3024
10. Hayden, F. G., S. J. Sperber, R. B. Belshe, R. D. Clover, A. J. Hay, and S. Pyke. 1991. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob. Agents Chemother. 35:1741-1747.
11. Higa, H. H., G. N. Rogers, and J. C. Paulson. 1985. Influenza virus hemagglutinins differentiate between receptor determinants bearing N-acetyl, N-glycolyl-, and N,O-diacetylneuraminic acids Virology 144:279-282.
12. kendal, A. P., and H. D. Klenk. 1991. Amantadine inhibits an early M2 protein-dependent event in the replication cycle of avian influenza (H7) viruses. Arch. Virol. 119:265-273.
13. Liu, C., and G. M. Air. 1993. Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuramimdase genes. Virology 194:403-407
14. Mast, E. E., J. P. Davis, M. W. Harmon, N. H. Arden, R. Circo, and G. E. Tyszka. 1991. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am. J. Epidemiol. 134:988-997.
15. McKimm-Breschkin, J. L. 1990 The use of tetramethylbenzidine for solid phase immunoassays. J. Immunol. Methods 135:277-280.
16. Morrison, J. F., and C. T. Walsh. 1988. The behaviour and significance of slow binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol 61:201-301.
17. Nobusawa, E., T. Aoyama, H. Kato, Y. Suzuki, Y. Tateno, and K. Nakajima. 1991. Comparison of complete amino acid sequences and receptor binding properties among 13 serotypes of hemagglutinins of influenza virus Virology 182:475-485.
18. Palese, P., and R. W. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA)-, mechanism of action. J. Gen. Virol 33:159-163.
19. Potier, M., L. Mameli, M. Belislem, L. Dallaire, and S. B. Melanxon. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
20. Rogers, G. N., J. C. Paulson, R. S. Daniels, J. J. Skehel, I. A. Wilson, and D. C. Wiley. 1983. Single amino acid substitutions in influenza hemagglutinin change receptor binding specificity. Nature (London) 304:76-78
21. Tulip, W. R., J. N. Varghese, A. T. Baker, A. van Donkelaar, W. G. Laver, R. G. Webster, and P. M. Colman. 1991. Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. J. Mol. Biol. 221:487-497.
22. Varghese, J. N., J. L. McKimm-Bresehkin, J. B. Caldwell, A. A. Kortt, and P. M. Colman. 1992. The structure of the complex between influenza virus neuraminidase and stalic acid, the viral receptor. Proteins 14:327-332.
23. von Itzstein, M., W. Y. Wu, G. B. Kok, M. S. Pegg, J. C. Dyason, B. Jin, T. V. Phan, M. L. Smythe, H. F. White, S. W. Oliver, P. M. Colrnan, J. N. Varghese, D. M. Ryan, J. M. Woods, R. C. Bethell, V. J. Hotham, J. M. Cameron, and C. R. Penn. 1993. Rational design of potent sialidase-based inhibitors of influenza virus replication Nature (London) 363:418-423.
24. Weis, W., J. H. Brown, S. Cusack, J. C. Paulson, J. J. Skehel, and D. C. Wiley. 1988. Structure of the influenza virus hemagglutinin complexed with its receptor, sialic acid. Nature (London) 333:426-431.
25. Woods, J. M., R. C. Bethell, J. A. V. Coates, N. Healy, S. A. Hiscox, B. A. Pearson, M. Ryan, J. Ticehurst, J. Tilling, S. M. Walcott, and C. R. Penn. 1993. 4-Guanidino-2,4-dideoxy-2.3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37:1473-1479.